Mark Coleman sold $4.0M of Axsome Therapeutics (AXSM)

Executed Feb 26, disclosed Feb 27, 1 day later.

Value, as filed

$4.0M

25,000 sh × $161.11

Executed

Feb 26

the trade date, as filed

Disclosed

Feb 27

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Mark Coleman Director profile →

Mark Coleman (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $4.0M of AXSM (25,000 sh × $161.11, as filed), executed Feb 26.

The name

AXSM

Axsome Therapeutics, Inc. AXSM · Healthcare · 34 filings in 24 months ticker →

Healthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Mark Coleman in AXSM

AXSMSALE Axsome Therapeutics, Inc. $160K
643 sh × $249.00
Exec Jun 10
Filed Jun 10 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $4.0M
17,537 sh across 3 lots
Exec May 29
Filed Jun 2 · 5:30 PM ET AXSMPURCHASE Axsome Therapeutics, Inc. $102K
800 sh × $127.20
Exec Sep 8 2025
Filed Sep 9 2025 · 8:11 PM ET AXSMSALE Axsome Therapeutics, Inc. $783K
7,500 sh across 2 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $322K
3,000 sh × $107.49
Exec May 20 2025
Filed May 20 2025 · 5:30 PM ET